Bulotta A - Search Results

1

GLP-1 stimulates glucose-derived de novo fatty acid synthesis and chain elongation during cell differentiation and insulin release.

Bulotta A, Perfetti R, Hui H, Boros LG. Bulotta A, et al. J Lipid Res. 2003 Aug;44(8):1559-65. doi: 10.1194/jlr.M300093-JLR200. Epub 2003 Jun 1. J Lipid Res. 2003. PMID: 12777469 Free article.

2

Glucagon-like peptide-1 promotes islet cell growth and inhibits apoptosis in Zucker diabetic rats.

Farilla L, Hui H, Bertolotto C, Kang E, Bulotta A, Di Mario U, Perfetti R. Farilla L, et al. Among authors: bulotta a. Endocrinology. 2002 Nov;143(11):4397-408. doi: 10.1210/en.2002-220405. Endocrinology. 2002. PMID: 12399437

3

The role of GLP-1 in the regulation of islet cell mass.

Bulotta A, Farilla L, Hui H, Perfetti R. Bulotta A, et al. Cell Biochem Biophys. 2004;40(3 Suppl):65-78. doi: 10.1385/cbb:40:3:65. Cell Biochem Biophys. 2004. PMID: 15289644 Review.

4

Cultured pancreatic ductal cells undergo cell cycle re-distribution and beta-cell-like differentiation in response to glucagon-like peptide-1.

Bulotta A, Hui H, Anastasi E, Bertolotto C, Boros LG, Di Mario U, Perfetti R. Bulotta A, et al. J Mol Endocrinol. 2002 Dec;29(3):347-60. doi: 10.1677/jme.0.0290347. J Mol Endocrinol. 2002. PMID: 12459036

5

GLP-1 receptor agonists are growth and differentiation factors for pancreatic islet beta cells.

Egan JM, Bulotta A, Hui H, Perfetti R. Egan JM, et al. Among authors: bulotta a. Diabetes Metab Res Rev. 2003 Mar-Apr;19(2):115-23. doi: 10.1002/dmrr.357. Diabetes Metab Res Rev. 2003. PMID: 12673779 Review.

6

Glucagon-like peptide 1 inhibits cell apoptosis and improves glucose responsiveness of freshly isolated human islets.

Farilla L, Bulotta A, Hirshberg B, Li Calzi S, Khoury N, Noushmehr H, Bertolotto C, Di Mario U, Harlan DM, Perfetti R. Farilla L, et al. Among authors: bulotta a. Endocrinology. 2003 Dec;144(12):5149-58. doi: 10.1210/en.2003-0323. Epub 2003 Aug 28. Endocrinology. 2003. PMID: 12960095

7

Novel strategies for the pharmacological management of type 2 diabetes.

Nourparvar A, Bulotta A, Di Mario U, Perfetti R. Nourparvar A, et al. Among authors: bulotta a. Trends Pharmacol Sci. 2004 Feb;25(2):86-91. doi: 10.1016/j.tips.2003.12.007. Trends Pharmacol Sci. 2004. PMID: 15102494 Review.

8

Gene expression profiling of cultured human islet preparations.

Hui H, Wang C, Li H, Bulotta A, D'Amico E, Khoury N, Nguyen E, Di Mario U, Chen IY, Perfetti R. Hui H, et al. Among authors: bulotta a. Diabetes Technol Ther. 2004 Aug;6(4):481-92. doi: 10.1089/1520915041705866. Diabetes Technol Ther. 2004. PMID: 15321003

9

The acquisition of an insulin-secreting phenotype by HGF-treated rat pancreatic ductal cells (ARIP) is associated with the development of susceptibility to cytokine-induced apoptosis.

Anastasi E, Santangelo C, Bulotta A, Dotta F, Argenti B, Mincione C, Gulino A, Maroder M, Perfetti R, Di Mario U. Anastasi E, et al. Among authors: bulotta a. J Mol Endocrinol. 2005 Apr;34(2):367-76. doi: 10.1677/jme.1.01595. J Mol Endocrinol. 2005. PMID: 15821103

10

Expression of Reg and cytokeratin 20 during ductal cell differentiation and proliferation in a mouse model of autoimmune diabetes.

Anastasi E, Ponte E, Gradini R, Bulotta A, Sale P, Tiberti C, Okamoto H, Dotta F, Di Mario U. Anastasi E, et al. Among authors: bulotta a. Eur J Endocrinol. 1999 Dec;141(6):644-52. doi: 10.1530/eje.0.1410644. Eur J Endocrinol. 1999. PMID: 10601969

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

80 results

Search Page

Filters